參考文獻

1. 中華醫學(xué)會(huì )醫學(xué)遺傳學(xué)分會(huì )遺傳病臨床實(shí)踐指南撰寫(xiě)組, 杜氏進(jìn)行性肌營(yíng)養不良的臨床實(shí)踐指南. 中華醫學(xué)遺傳學(xué)雜志, 2020. 37(3): p. 258-262.

2. Duan, D., et al., Duchenne muscular dystrophy. Nat Rev Dis Primers, 2021. 7(1): p. 13.

3. Verhaart, I.E.C. and A. Aartsma-Rus, Therapeutic developments for Duchenne muscular dystrophy. Nat Rev Neurol, 2019. 15(7): p. 373-386.

4. Sheikh, O. and T. Yokota, Developing DMD therapeutics: a review of the effectiveness of small molecules, stop-codon readthrough, dystrophin gene replacement, and exon-skipping therapies. Expert Opin Investig Drugs, 2021. 30(2): p. 167-176.

5. Li, Q., et al., Novel Partial Exon 51 Deletion in the Duchenne Muscular Dystrophy Gene Identified via Whole Exome Sequencing and Long-Read Whole-Genome Sequencing. Front Genet, 2021. 12: p. 762987.